Chinese Governemt Deligation Came to Meet Giostar San Diago California
GIOSTAR will bring team of experts from USA to develop the advance stem cell transplant program at San Vicente Foundation Hospital. This collaboration will bring the country of Columbia in par with USA in regards to availability of the advance stem cell transplant for many incurable diseases.
This much needed collaboration with two private organizations from USA and Columbia will be the blessings for the people of Columbia and synergistically aligns with the core values of San Vicente Foundation.
Note: Result varies from patient to patient. These testimonials do not constitute typical results nor do we claim otherwise.
Dr. Anand Shrivastava, Chairman – GIOSTAR U.S.A. Presenting the GUSI Peace Prize 2015 to Former Health Minister of China Dr. Huang Jiefu for Human Rights
Dr. A. S. Srivastava
Stem Cell Core Labratory
Salk Institute for Biological Studies La Jolla
Dear Dr. Srivastava,
On behalf of the editorial board of “Current Pharmaceutical Design”, I would like to propose your name to be considered as an Executive Guest Editor for a thematic issue of the journal in a hot topic area.
“Current Pharmaceutical Design” is a leading international journal, which publishes frontier reviews in important fields of drug discovery. The journal is published by Bentham Science Publishers and has been widely acclaimed because of its excellent standards and the high quality of publications. It is abstracted/indexed in a number of major abstracting/indexing agencies, Impact Factor: 6.452 (2014 SCI Journal Citation Reports). Each issue is published under a Guest Editor who is an authority in the field and who is responsible for soliciting top class articles covering various important aspects of the field from leading authorities.
Bentham Science Publishers is currently publishing 42 issues of the journal annually. These “theme issues” contain articles in important fields of current research activity written by eminent experts in the field. The Guest Editor is responsible for soliciting top class articles covering various important aspects of the selected topic from leading authorities in the field. In view of current demand for the journal, the publishers are soliciting additional topic themes relevant to pharmaceutical design. Please visit the website of Current Pharmaceutical Design for more information.
If you are interested in being considered for the post of Executive Guest Editor, then please send us the following:
1. Title of your topic or theme.
2. List of authors (along with their affiliation) and the titles of the articles they are contributing.
3. Brief introduction of the issue.
4. A description stating how the subject will contribute to the field.
5. Your complete CV and detailed list of publications.
The aim of the journal is to provide readers with comprehensive accounts of recent developments in the frontier areas of the field. The articles should take the form of full-length manuscripts of recent developments in important areas related to pharmaceutical design within a therapeutic field. They could include accounts of the author’s research work combined with a review of the recent literature so that the readers will not only have the opportunity of benefiting from the author’s contribution, but will also gain access to a broader perspective of the field.
We will need to have about 250-300 printed pages in the journal issue from about 10-15 authors who are leading experts in the field (for manuscript preparation details please visit Author Guidelines Please note that no research articles will be accepted as a part of the thematic issue.
As the Executive Guest Editor, you will be required to contribute a one-page foreword highlighting the importance of the chosen topic and of the articles contained in the issue. You may also contribute an article to the issue yourself. You will be entitled to free online subscription to the whole volume of the journal for the year in which your issue has appeared. Appointment as the Executive Guest Editor is renewable by mutual agreement.
I would be grateful if you could please send your reply to me at firstname.lastname@example.org. as soon as possible along with the choice of the proposed theme/ topic area of your interest.
I shall be looking forward to receiving your positive reply.
Prof. William A. Banks
Editor-in-Chief Current Pharmaceutical Design